Cantitate/Preț
Produs

Multichain Immune Recognition Receptor Signaling: From Spatiotemporal Organization to Human Disease: Advances in Experimental Medicine and Biology, cartea 640

Editat de Alexander Sigalov
en Limba Engleză Paperback – 23 noi 2010

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 104108 lei  6-8 săpt.
  Springer – 23 noi 2010 104108 lei  6-8 săpt.
Hardback (1) 100841 lei  39-44 zile
  Springer – 27 oct 2008 100841 lei  39-44 zile

Din seria Advances in Experimental Medicine and Biology

Preț: 104108 lei

Preț vechi: 109586 lei
-5% Nou

Puncte Express: 1562

Preț estimativ în valută:
19928 21426$ 16613£

Carte tipărită la comandă

Livrare economică 19 decembrie 24 - 02 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781441918871
ISBN-10: 1441918876
Pagini: 388
Ilustrații: XXVII, 357 p. 70 illus., 3 illus. in color.
Dimensiuni: 155 x 235 x 20 mm
Greutate: 0.54 kg
Ediția:Softcover reprint of hardcover 1st ed. 2008
Editura: Springer
Colecția Springer
Seria Advances in Experimental Medicine and Biology

Locul publicării:New York, NY, United States

Public țintă

Research

Cuprins

MIRRs: Structure and Physiological Function.- T-Cell Receptor.- B-Cell Receptor.- Fc Receptors.- Natural Killer Cell Receptors.- Platelet Glycoprotein VI.- MIRR Signaling: Possible Mechanisms and the Techniques to Study and Visualize.- Clustering Models.- Segregation Models.- Kinetic Proofreading Model.- Serial Triggering Model.- Conformational Model.- Permissive Geometry Model.- Signaling Chain Homooligomerization (SCHOOL) Model.- Visualization of Cell-Cell Interaction Contacts-Synapses and Kinapses.- Visualization of Protein Interactions in Living Cells.- MIRR Signaling and Therapy of Immune Disorders.- Immunogenicity in Peptide-Immunotherapy: From Self/Nonself to Similar/Dissimilar Sequences.- Therapeutic Application of Transmembrane T and Natural Killer Cell Receptor Peptides.- Fc Receptor Targeting in the Treatment of Allergy, Autoimmune Diseases and Cancer.- Therapeutic Blockade of T- Cell Antigen Receptor Signal Transduction and Costimulation in Autoimmune Disease.- MHC and MHC-Like Molecules: Structural Perspectives on the Design of Molecular Vaccines.- SCHOOL Model and New Targeting Strategies.- Immune Receptor Signaling, Aging and Autoimmunity.- Viral Pathogenesis, Modulation of Immune Receptor Signaling and Treatment.

Notă biografică

ALEXANDER SIGALOV, PhD, is a Research Assistant Professor in the Department of Pathology at the University of Massachusetts Medical School in Worcester, Massachusetts, USA. His main research interests include protein intrinsic disorder and oligomericity in the context of transmembrane signal transduction, the molecular mechanisms underlying immune receptor-mediated signaling and ways to control these processes and thus to modulate the immune response, as well as the development and applications of novel targets and strategies for innovative immune therapy. He discovered and investigated a very unusual and unique biophysical phenomenon, the homooligomerization of intrinsically disordered proteins, thus providing the first evidence for the existence of specific interactions between unfolded protein molecules. In the field of immunology, he unraveled a long-standing mystery of transmembrane signaling and immune cell activation triggered by multichain immune recognition receptors. Later, he developed a novel concept of platelet inhibition and invented a novel class of platelet inhibitors. In the field of immune therapy, he proposed new therapeutic strategies for a variety of malignancies and immune disorders, including immunodeficiencies, inflammatory and autoimmune diseases, allergy and HIV. He is a member of the American Association for the Advancement of Science and the Biophysical Society, USA. Alexander Sigalov received his academic degrees (MSc in Chemistry and a PhD in Organic Chemistry) from Moscow State University, Russia.